Maternal exposure to leflunomide and methotrexate in a patient with adult-onset Still's disease

Rheumatology

Volumn 49, Issue 9, 2010, Pages 1787-1789

  Sayarlioglu, Mehmet ^a   Sahin, Murat ^a   Cetin, Gozde Yildirim ^a   Avan, Rustem ^a   Cerit, Mustafa ^a  

^a KAHRAMANMARAS SUTCU IMAM UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

COLESTYRAMINE; FOLIC ACID; LEFLUNOMIDE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE;

ADD ON THERAPY; ADULT; ADULT ONSET STILL DISEASE; AMNIOCENTESIS; CASE REPORT; CESAREAN SECTION; CONTRACEPTION; DISEASE ACTIVITY; DRUG WITHDRAWAL; ENVIRONMENTAL EXPOSURE; FEMALE; FETUS ECHOGRAPHY; FETUS RISK; GESTATIONAL AGE; HOSPITAL ADMISSION; HUMAN; LETTER; NEWBORN INTENSIVE CARE; PATIENT COUNSELING; PHYSICAL EXAMINATION; PREGNANCY TERMINATION; PRIORITY JOURNAL; TREATMENT DURATION; VITAMIN SUPPLEMENTATION;

ANTIRHEUMATIC AGENTS; CESAREAN SECTION; FEMALE; HUMANS; INFANT, NEWBORN; ISOXAZOLES; MALE; METHOTREXATE; PREGNANCY; STILL'S DISEASE, ADULT-ONSET; YOUNG ADULT;

EID: 77955731728     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keq132     Document Type: Letter

References (10)

1. Brent RL. Teratogen update: reproductive risks of leflunomide (Arava); a pyrimidine synthesis inhibitor: counseling women taking leflunomide before or during pregnancy and men taking leflunomide who are contemplating fathering a child. Teratology 2001;63:106-12.
2. Chakravarty EF, Sanchez-Yamamoto D, Bush TM. The use of disease modifying antirheumatic drugs in women with rheumatoid arthritis of childbearing age: a survey of practice patterns and pregnancy outcomes. J Rheumatol 2003;30:241-6.
3. De Santis M, Straface G, Cavaliere A, Carducci B, Caruso A. Paternal and maternal exposure to leflunomide: pregnancy and neonatal outcome. Ann Rheum Dis 2005;64:1096-7.
4. Neville CE, McNally J. Maternal exposure to leflunomide associated with blindness and cerebral palsy. Rheumatology 2007;46:1506.
5. Chambers CD, Johnson DL, Robinson LK et al. Birth outcomes in pregnant women taking leflunomide. Arthritis Rheum. Advance Access published January 28, 2010, doi:10.1002/art.27358.
6. Østensen M, Hartmann H, Salvesen K. Low dose weekly methotrexate in early pregnancy. A case series and review of the literature. J Rheumatol 2000;27:1872-5.
7. Feldkamp M, Carey JC. Clinical teratology counseling and consultation case report: low dose methotrexate exposure in early weeks of pregnancy. Teratology 1993;47:533-9.
8. Bawle EV, Conard JV, Weiss L. Adult and two children with fetal methotrexate syndrome. Teratology 1998;57:51-5.
9. Visser K, Katchamart W, Loza E et al. Multinational evidence-based recommendations for the use of metho-trexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheuma-tologists in the 3E Initiative. Ann Rheum Dis 2009;68: 1086-93.
10. Østensen M, Förger F. Management of RA medications in pregnant patients. Nat Rev 2009;5:382-90.